TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Chemotechnique Mb Diagnostics AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
75,726
|
69,333
|
53,946 |
| Financial expenses |
9
|
12
|
1 |
| Earnings before taxes |
19,844
|
19,508
|
14,459 |
| EBITDA |
20,320
|
20,235
|
15,736 |
| Total assets |
60,213
|
59,764
|
48,498 |
| Current assets |
57,599
|
56,677
|
44,617 |
| Current liabilities |
10,035
|
17,470
|
15,128 |
| Equity capital |
49,868
|
41,946
|
32,503 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
37
|
35
|
32 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
82.8%
|
70.2%
|
67.0% |
| Turnover per employee |
2,047
|
1,981
|
1,686 |
| Profit as a percentage of turnover |
26.2%
|
28.1%
|
26.8% |
| Return on assets (ROA) |
33.0%
|
32.7%
|
29.8% |
| Current ratio |
574.0%
|
324.4%
|
294.9% |
| Return on equity (ROE) |
39.8%
|
46.5%
|
44.5% |
| Change turnover |
5,143
|
11,559
|
4,697 |
| Change turnover % |
7%
|
20%
|
10% |
| Chg. No. of employees |
2
|
3
|
2 |
| Chg. No. of employees % |
6%
|
9%
|
7% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.